News Pulmocide raises $30m for inhaled anti-infectives A UK biotech company has raised $30 million to fund development of its treatments for respiratory infections.
Sales & Marketing Sponsored Health Trends 2025: Reimagining What's Possible Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
